Cutaneous Lymphomas: Unusual Cases 2: v. 2

leondumoulin.nl: Cutaneous Lymphomas: Unusual Cases 2 (v. 2): B. Fruet, P. Colling, G. Burg, W. Kempf, S. Michaelis, J. Feit.
Table of contents

Ann Intern Med ; Human T-lymphotropic virus type I in Japan. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group Br J Haematol ; Clonal integration and expression of human T-cell lymphotropic virus type I in carriers detected by polymerase chain reaction and inverse PCR. Am J Hematol ; Yamada Y, Tomonaga M.

The current status of therapy for adult T-cell leukaemia-lymphoma in Japan.

Result Filters

A report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of patients and guidelines for diagnosis and treatment. Most primary cutaneous CDpositive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol ; EORTC classification for primary cutaneous lymphomas: Comparison with anaplastic large-cell lymphoma of nodal origin. Subcutaneous panniculitis-like T-cell lymphoma: Definition, classification, and prognostic factors: Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma: Report of 7 cases.

A morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol ; Clinicopathological findings of four cases. Classification of cytotoxic T-cell and natural killer cell lymphomas. Clinicopathological features and prognosis. Clinical features, tumor immunophenotype, and treatment outcome in patients. J Clin Oncol ; Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. The role of Mig, the monokine induced by interferon-gamma, and P, the interferon-gamma-inducible protein, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease.

Natural killer cell neoplasms. A retrospective analysis of 23 new cases and cases from the literature. Acta Derm Venereol ; Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Peripheral T-cell lymphomas unspecified presenting in the skin: Analysis of prognostic factors in a group of 82 patients. A distinct hematological entity? Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

Neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon. Am J Clin Pathol ; Primary cutaneous marginal zone B-cell lymphoma.

Am J Clin Pathol ; Suppl: Sroa N, Magro CM. Pediatric primary cutaneous marginal zone lymphoma: In association with chronic antihistamine use. J Cutan Pathol ;33 Suppl 2: Pediatr Dev Pathol ;9: Primary cutaneous marginal zone B-cell lymphoma: Report of a nationwide study.

Korean J Pathol ; Clinicopathologic analysis of cutaneous lymphoma in Taiwan: Arch Pathol Lab Med ; Cutaneous lymphoma incidence patterns in the United States: A population-based study of cases. The spectrum of cutaneous lymphomas in Japan: A study of 62 cases based on the World Health Organization Classification.

J Cutan Pathol ; Wohl Y, Tur E. Environmental risk factors for mycosis fungoides. Environmental Factors in Skin Diseases. Hinds GA, Heald P.

[Primary cutaneous lymphoma-a case series of patients]. - PubMed - NCBI

Cutaneous T-cell lymphoma in skin of color. J Am Acad Dermatol ; Kempf W, Sander CA. Classification of cutaneous lymphomas - An update. Hypopigmented mycosis fungoides versus mycosis fungoides with concomitant hypopigmented lesions: Same disease or different variants of mycosis fungoides? Update on epidemiology of cutaneous T-cell lymphoma. Curr Derm Rep ;2: A rare presentation of a great masquerade.

Gulf J Dermatol Venereol ; Thompson D, Whittaker S.

Reports of Radiotherapy and Oncology

Cutaneous manifestations of HTLV J Am Acad Dermatol ;54 3: Report of three different forms. Acta Derm Venereol ; Report of two cases. Am J Dermatopathol ; The clinical course in our patient, with rapid disappearance of all skin lesions and no relapse during follow-up, is highly unusual for patients with CGD-TCL. The disappearance of all skin lesions following cessation of etanercept strongly suggests a direct causal relationship between etanercept therapy and the development of CGD-TCL in our patient. An additional effect of the increased dose of dexamethasone from 0.

Most reports concerned cases of mycosis fungoides. Two other reports described cases of Sezary syndrome, one of which was fatal despite aggressive systemic treatment 5.


  • The Lead Ladder: Turn Strangers Into Clients, One Step at a Time.
  • [Primary cutaneous lymphoma-a case series of 163 patients].?
  • Cutaneous lymphomas: An update Singh A, Arava S, Singh M K - Indian J Dermatopathol Diagn Dermatol.
  • Supplemental Content!
  • Quality of Life!

Finally, Michot et al. In a recent report, Beyer et al. Letter to the Editor.